Meihua International Medical Technologies Co Ltd (MHUAF)
OTHER OTC:MHUAF
Want to see MHUAF full AI Analyst Report?
Top Page
Meihua International Medical Technologies Co Ltd
(OTC:MHUAF)
Select Model
Select Model
Rating:59Neutral
Price Target:
$9.00
▲(50.00% Upside)
Action:Reiterated
Date:05/04/26
The score is held back primarily by weakening operating results and especially volatile/declining cash generation, despite a conservatively financed balance sheet. Technicals are modestly supportive in the near term, and the very low P/E provides valuation support.
Positive Factors
Conservative balance sheet
Low leverage and a growing equity base provide durable financial flexibility. With modest total debt relative to substantial equity and rising assets, the company can withstand cyclical pressures, fund operations or targeted investments without immediate refinancing risk, preserving strategic optionality.
Negative Factors
Revenue decline and margin compression
A sharp revenue drop and meaningful margin erosion signal weakening demand or pricing pressure and compress long-term earnings power. Lower top-line and slimmer gross margins reduce reinvestment capacity and strain profitability sustainability, increasing reliance on structural recovery to restore prior returns.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet
Low leverage and a growing equity base provide durable financial flexibility. With modest total debt relative to substantial equity and rising assets, the company can withstand cyclical pressures, fund operations or targeted investments without immediate refinancing risk, preserving strategic optionality.
Read all positive factors
Meihua International Medical Technologies Co Ltd (MHUAF) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$6.05M
Dividend YieldN/A
Average Volume (3M)258.45K
Price to Earnings (P/E)<0.1
Beta (1Y)0.90
Revenue Growth-36.24%
EPS Growth-61.74%
CountryUS
Employees619
SectorHealthcare
Sector Strength45
IndustryMedical - Instruments & Supplies
Share Statistics
EPS (TTM)15.09
Shares Outstanding697,914
10 Day Avg. Volume415,554
30 Day Avg. Volume258,455
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)<0.01
Price to Sales (P/S)0.01
P/FCF Ratio1.39
Enterprise Value/Market Cap-0.04
Enterprise Value/Revenue>-0.01
Enterprise Value/Gross Profit-0.01
Enterprise Value/Ebitda-0.03
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Meihua International Medical Technologies Co Ltd Business Overview & Revenue Model
Company Description
Meihua International Medical Technologies Co., Ltd. engages in the research and development, manufacture, and sale of medical devices in the People's Republic of China. The company offers Class I disposable medical devices, including disposable me...
How the Company Makes Money
null...
Meihua International Medical Technologies Co Ltd Financial Statement Overview
Summary
Income Statement
46
Neutral
Balance Sheet
82
Very Positive
Cash Flow
38
Negative
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 61.79M | 96.91M | 97.10M | 103.35M | 104.04M |
| Gross Profit | 18.99M | 33.30M | 33.09M | 38.10M | 39.81M |
| EBITDA | 8.83M | 15.70M | 15.77M | 11.65M | 27.03M |
| Net Income | 6.78M | 10.84M | 11.63M | 6.24M | 20.95M |
Balance Sheet | |||||
| Total Assets | 207.18M | 186.24M | 171.92M | 163.58M | 136.86M |
| Cash, Cash Equivalents and Short-Term Investments | 15.15M | 15.96M | 16.93M | 26.74M | 8.15M |
| Total Debt | 8.99M | 7.95M | 7.33M | 6.81M | 5.18M |
| Total Liabilities | 18.25M | 27.26M | 25.08M | 24.90M | 29.09M |
| Stockholders Equity | 188.93M | 158.98M | 146.33M | 138.12M | 106.81M |
Cash Flow | |||||
| Free Cash Flow | 554.25K | 14.50M | -2.41M | -11.86M | -904.89K |
| Operating Cash Flow | 569.88K | 14.64M | 2.28M | -9.16M | -54.66K |
| Investing Cash Flow | -20.13M | -20.42M | -12.46M | -8.62M | -833.82K |
| Financing Cash Flow | 17.19M | 6.21M | 706.13K | 37.25M | 1.86M |
Meihua International Medical Technologies Co Ltd Technical Analysis
Positive
6.00
Price Trends
8.20
Positive
7.76
Positive
18.15
Negative
Market Momentum
0.14
Negative
62.54
Neutral
78.57
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MHUAF, the sentiment is Positive. The current price of 6 is below the 20-day moving average (MA) of 8.51, below the 50-day MA of 8.20, and below the 200-day MA of 18.15, indicating a neutral trend. The MACD of 0.14 indicates Negative momentum. The RSI at 62.54 is Neutral, neither overbought nor oversold. The STOCH value of 78.57 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for MHUAF.
Meihua International Medical Technologies Co Ltd Risk Analysis
Meihua International Medical Technologies Co Ltd disclosed 80 risk factors in its most recent earnings report. Meihua International Medical Technologies Co Ltd reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 3 New Risks
1.
Techniques employed by short sellers may drive down the market price of our Ordinary Shares. Q4, 2023
2.
Future sales of our Ordinary Shares, whether by us or our shareholders, could cause our share price to decline. Q4, 2023
3.
Raising additional capital and the sale of additional Ordinary Shares or other equity securities could result in dilution to our shareholders, while the incurrence of debt may impose restrictions on our operations. Q4, 2023
Meihua International Medical Technologies Co Ltd Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
59 Neutral | $6.05M | 0.10 | 5.90% | ― | -36.24% | -61.74% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
47 Neutral | $195.20K | -1.79 | ― | ― | ― | ― | |
44 Neutral | $6.35M | -0.74 | -74.10% | ― | 74.57% | 60.81% | |
42 Neutral | $2.89M | -0.06 | ― | ― | ― | 99.39% |
* Healthcare Sector Average
MHUAF
Meihua International Medical Technologies Co Ltd
8.45
-29.65
-77.82%
GCTK
GlucoTrack
0.50
-7.50
-93.75%
LUCY
Innovative Eyewear, Inc.
1.02
-1.84
-64.34%
WOK
WORK Medical Technology Group LTD
0.11
-6,999.89
-100.00%
Meihua International Medical Technologies Co Ltd Corporate Events
Meihua International Seeks Review of Nasdaq Delisting After Panel Upholds Removal
Mar 2, 2026
Meihua International Medical Technologies Co., Ltd., a China-based medical device maker whose Class A ordinary shares had been listed on Nasdaq, has seen its stock shifted to trading on the OTC Marketplace under the symbol MHUAF after a Nasdaq sta...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.